Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Acadia Pharmaceuticals Inc

NASDAQ: ACAD · Life Sciences · 7 alerts · CIK 1070494

Share price
$18.67Close, Nov 16
Market cap
$3.23B
Shares outstanding
172.83MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Acadia Pharmaceuticals Inc filings on SEC EDGAR ↗

9:09 AM ET 8-K
Court & Legal Update

Acadia Pharmaceuticals Court & Legal Update

The U.S. District Court for the Southern District of California has granted preliminary approval for a settlement of a stockholder derivative action against Acadia Pharmaceuticals and certain of its officers and directors. The settlement resolves claims related to the company's drug pimavanserin (NUPLAZID) and includes the implementation of corporate governance reforms and the payment of plaintiff attorney fees. A final settlement hearing is scheduled for January 13, 2027.

Counterparty
Kanner et al.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.